» Articles » PMID: 8145781

Helicobacter Pylori Infection and Gastric Lymphoma

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1994 May 5
PMID 8145781
Citations 472
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Helicobacter pylori infection is a risk factor for gastric adenocarcinoma. We examined whether this infection is also a risk factor for primary gastric non-Hodgkin's lymphoma.

Methods: This nested case-control study involved two large cohorts (230,593 participants). Serum had been collected from cohort members and stored, and all subjects were followed for cancer. Thirty-three patients with gastric non-Hodgkin's lymphoma were identified, and each was matched to four controls according to cohort, age, sex, and date of serum collection. For comparison, 31 patients with nongastric non-Hodgkin's lymphoma from one of the cohorts were evaluated, each of whom had been previously matched to 2 controls. Pathological reports and specimens were reviewed to confirm the histologic type of the tumor. Serum samples from all subjects were tested for H. pylori IgG by an enzyme-linked immunosorbent assay.

Results: Thirty-three cases of gastric non-Hodgkin's lymphoma occurred a median of 14 years after serum collection. Patients with gastric lymphoma were significantly more likely than matched controls to have evidence of previous H. pylori infection (matched odds ratio, 6.3; 95 percent confidence interval, 2.0 to 19.9). The results were similar in both cohorts. Among the 31 patients with nongastric lymphoma, a median of six years had elapsed between serum collection and the development of disease. No association was found between nongastric non-Hodgkin's lymphoma and previous H. pylori infection (matched odds ratio, 1.2; 95 percent confidence interval, 0.5 to 3.0).

Conclusions: Non-Hodgkin's lymphoma affecting the stomach, but not other sites, is associated with previous H. pylori infection. A causative role for the organism is plausible, but remains unproved.

Citing Articles

Seroprevalence in Rheumatoid Arthritis Patients with Interstitial Lung Disease.

Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Fujimori M Biomark Insights. 2024; 19:11772719241297171.

PMID: 39640205 PMC: 11618895. DOI: 10.1177/11772719241297171.


Clinicopathological Characteristics of Extranodal Marginal Zone Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT-Lymphoma) of the Intestine: A Single Center Analysis.

Steinbrecher O, Kiesewetter B, Dolak W, Brand R, Simonitsch-Klupp I, Raderer M Hematol Oncol. 2024; 43(1):e70007.

PMID: 39624879 PMC: 11612847. DOI: 10.1002/hon.70007.


O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.

Vasquez Martinez I, Perez-Campos E, Perez-Campos Mayoral L, Cruz Luis H, Pina Canseco M, Zenteno E Int J Mol Sci. 2024; 25(18).

PMID: 39337387 PMC: 11432004. DOI: 10.3390/ijms25189896.


Two cases demonstrate an association between Tropheryma whipplei and pulmonary marginal zone lymphoma.

Haslbauer J, Wiegand C, Hamelin B, Ivanova V, Menter T, Savic Prince S Infect Agent Cancer. 2024; 19(1):33.

PMID: 39068468 PMC: 11282790. DOI: 10.1186/s13027-024-00597-0.


Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates.

Islam J, Yano Y, Okamoto A, Matsuda R, Shiraishi M, Hashimoto Y Sci Rep. 2024; 14(1):12066.

PMID: 38802465 PMC: 11130178. DOI: 10.1038/s41598-024-62200-1.